Chemical Structure : Cyy-272
货号: PC-28711Not For Human Use, Lab Use Only.
Cyy-272 is an orally active JNK inhibitor with IC50 of 1.25 μM, 1.07 μM and 1.24 μM for JNK1, JNK2 and JNK3, attenuates LPS-stimulated Acute lung injury (ALI), exhibits anti-inflammation activity by inhibiting JNK phosphorylation.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Cyy-272 is an orally active JNK inhibitor with IC50 of 1.25 μM, 1.07 μM and 1.24 μM for JNK1, JNK2 and JNK3, attenuates LPS-stimulated Acute lung injury (ALI), exhibits anti-inflammation activity by inhibiting JNK phosphorylation.
Cyy-272 inhibits the inflammatory cytokine expression in MPMs, decreases the overexpression of TNF-α, IL-6 and IL-1β mRNA in LPS-challenged MPMs.
Cyy-272 inhibits the inflammatory cytokine expression in ALI mice.
Cyy-272 alleviates LPS-induced ALI in vivo.
Cyy-272 exerts anti-inflammatory effects by specifically inhibiting LPS-induced JNK phosphorylation in RAW 264.7.
| 分子量 | 435.48 | |
| 分子式 | C23H23F2N7 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Liu Q, et al. Toxicol Appl Pharmacol. 2021 Oct 1;428:115648.
2. Liu X, et al. Biomed Pharmacother. 2024 Sep;178:117172.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright